Navigation Links
Merck Company Foundation Announces HIV Care Collaborative with Atlanta, Houston and Philadelphia Health Departments
Date:7/19/2012

WHITEHOUSE STATION, N.J., July 19, 2012 /PRNewswire/ -- The Merck Company Foundation announces the launch of a three-year, $3 million initiative that will support the health departments in Atlanta, Houston and Philadelphia to connect more people living with HIV in these high-burden communities to the care they need to stay healthy. The initiative will be launched with program partners on Sunday, July 22, 2012 at the start of the XIX International AIDS Conference.

The HIV Care Collaborative for Underserved Populations in the United States aligns with President Obama's National HIV/AIDS Strategy's goals which include entering and retaining more patients in care and is designed to support existing programs that have the greatest potential to reduce new HIV infections.   According to the Centers for Disease Control and Prevention, 1.2 million people in the United States are living with HIV infection, with 50,000 new infections each year.  A third of Americans with known HIV infections are not receiving health care and 20 to 40 percent of patients fail to establish care within six months of receiving an HIV-positive diagnosis.

"Too many people living with HIV/AIDS are not getting the health care they need to stay healthy and contribute to healthy communities," said Geralyn S. Ritter, senior vice president, Global Public Policy & Corporate Responsibility, Merck & Co., Inc. and president, The Merck Company Foundation. "Merck has a long-standing commitment to expanding access to health care and helping respond to the HIV/AIDS epidemic, and the HIV Care Collaborative reinforces this commitment here in the United States."

Each of the selected health departments will receive up to $1 million over three years, to enhance existing efforts and foster other innovative approaches to better serve people living with HIV/AIDS and prevent its further spread.  The communities will address local provider-based an
'/>"/>

SOURCE The Merck Company Foundation
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
2. Ambrx Collaborates with Merck to Design and Develop Biologic Drug Conjugates
3. GeneTex Antibody Company to Launch New Line of Primary Antibodies for the Study of Spindle Assembly
4. Monsanto Declared Worst Company of 2011 by NaturalSociety
5. Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager
6. Oxford Finance Provides $15 Million Senior Secured Credit Facility to Private Equity Backed Healthcare Services Company
7. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
8. Meaningful Use Stage Two: The Advisory Board Company Helps Hospitals Set Strategy
9. Aneesh Chopra to Serve as Senior Advisor to The Advisory Board Company
10. Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA
11. Incline Therapeutics to Present at the Cowen and Company 32nd Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013 Mold remediation could take ... that there is a way to cut down the process' ... its latest post the details of a method how ... , Mold could be prevented, My Cleaning Products said. But ... stated that a mold remediation must then be promptly implemented ...
(Date:5/22/2013)... Envera announced today that Michael McErlean ... McErlean has an extensive background in cell production and ... career. , Mike Matheny, President and Owner ... Mike join our team”. “Mike’s background is perfectly suited ... and downstream processing equipment”, added Matheny. “Mike’s hands ...
(Date:5/22/2013)... 2013  Moderna Therapeutics, the pioneering company developing messenger ... the in vivo production of therapeutic proteins, ... will join Moderna in early July as its first ... proven leader in the design and implementation of information ... to translation, clinical operations and commercial preparedness. John has ...
(Date:5/21/2013)...  The Lindsley F. Kimball Research Institute of the New ... Grand Challenges Explorations winner, an initiative funded by the ... Sara Lustigman , Head of the Laboratory of Molecular ... project, titled Innovative 3-D in vitro culturing ... screen drugs to help eliminate onchocerciasis (river blindness) in ...
Breaking Biology Technology:How to Kill Mold While Saving Thousands of Dollars on Mold Remediation Projects Explained by My Cleaning Products 2Envera Appoints Michael McErlean Fermentation Manager 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 3New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 2New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 3
... Life Sciences,Holdings, Inc. (Nasdaq: ADLS ) a biopharmaceutical ... drugs in the,therapeutic areas of infection, cancer and respiratory ... Leaders Bank to increase,its line of credit from $4 ... of,maturity by 12 months to January 1, 2011. The ...
... Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ), a clinical-stage ... novel medicines in the areas of,hepatitis C and ... the third quarter ended September 30, 2008., ... of our hepatitis C,development programs," said Steve Worland ...
... CALGARY, Oct. 23 /PRNewswire-FirstCall/ - Oncolytics Biotech ... an abstract entitled "A Phase I,Study to ... Docetaxel in Patients with Advanced Malignancies" will ... Journal of Immunotherapy, the official,journal of the ...
Cached Biology Technology:Advanced Life Sciences Completes Debt Transaction 2Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 2Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 3Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 4Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 5Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 6Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 7Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 8Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting 2Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting 3
(Date:5/20/2013)... USA New Geology articles posted ... 2013 cover a wide swath of geoscience subdisciplines, ... geophysics, and paleobotany. Locations studied include Siberia; the ... Alpi Apuane, Italy; Ukraine; Mars; and the Southeastern ... 1. Rubies, jadeite, and plate tectonics;, 2. The ...
(Date:5/19/2013)... strain of electricity-producing bacteria that can grow using hydrogen ... as its sole source of carbon. Researchers at ... the 113th General Meeting of the American Society for ... production solely on hydrogen," says Amit Kumar, a researcher ... part of the Lovley Lab Group at the university. ...
(Date:5/18/2013)... AGA Research Foundation is honored to announce the first ... Cancer, which will support Andrew D. Rhim, MD, from ... Pennsylvania, Philadelphia, as he furthers his research on the ... progression. , "The AGA Research Foundation is humbled to ... and AGA Legacy Society members," said Nicholas F. LaRusso, ...
Breaking Biology News(10 mins):New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 2New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 3New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 4New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 5New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 6New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 7New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 8New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 9New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 10New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 11AGA Research Foundation grant furthers digestive cancer research 2
... Policy Center is hosting a lecture and symposium Tuesday, ... better understand the disastrous floods of summer 2008. ... topic of this symposium in The Forkenbrock Series on ... the science of floods to the psychological impact of ...
... more than 30 million acres of agricultural land ... numbers have been increasing significantly since then. With ... seeking environmentally friendlier alternatives to conventional plastic mulch. ... higher yields, increased quality, improved disease and insect ...
... Otto, NC New research by U.S. Forest Service ... hemlock woolly adelgid is killing hemlock trees faster than ... carbon cycle of these forests. SRS researchers and cooperators ... the most recent issue of the journal Ecosystems ...
Cached Biology News:Public Policy Center hosts flood symposium March 10-12 2Biodegradable mulch films on the horizon 2Study finds hemlock trees dying rapidly, affecting forest carbon cycle 2
... except that it uses a deep-UV deuterium bulb, ... comes with a shutter (controlled via a TTL ... Light Source produces a powerful, stable output from ... light source are available, providing a wavelength range ...
... and mitochondrial membrane potential. The mitochondrial permeability ... the initiation of cellular apoptosis. This process ... the electrochemical gradient across the mitochondrial membrane, ... membrane potential (YD). Loss of mitochondrial YD ...
... The NOVOstar is an exciting product ... Previously, cell-based assays required the use of ... accessibility for scientists in the assay development ... necessary for cell-based assays as well as ...
... Clamp One can operate as a Voltage Clamp, ... (Dynamic) Clamp in electrophysiology research applications. Performance in ... analog equipment. • This ... advances in the capabilities of Digital Signal Processing ...
Biology Products: